Other immune checkpoints that have played significant roles are CD276, leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2), and CD47, which were upregulated in CSCs and led to a weakened or damaged host anti-tumor response. This evidence concerns the gene CD276 and neoplasm.